Filing
Spy
Filing
Spy
Home
About
FNCH
Finch Therapeutics Group Inc
Clinical-stage biotechnology company developing microbiome therapies
CUSIP: 31773D101
Healthcare
US
1 holder
Ownership
Activity
2023 Q1
1 of 9 quarters
Total Value
$793.0K
Total Shares
2.02M
Net Share Change
+1.00M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$793.0K
2.02M
0.0%
ADD
+1.00M
(+98.1%)
Baupost Group LLC
$793.0K
2.02M shares
ADD
+1.00M
(+98.1%)
FNCH — Finch Therapeutics Group Inc - FilingSpy